Key result
The HAVOC score stratifies AF risk after cryptogenic stroke or TIA with an AUC of 0.77.
Why the study?
Can clinical variables predict the development of atrial fibrillation in adult patients with cryptogenic stroke or transient ischemic attack?
Cohort (n=9,589)
Can clinical variables predict the development of atrial fibrillation in adult patients with cryptogenic stroke or transient ischemic attack?
Effect estimate: AUC 0.77
The HAVOC score, utilizing 7 clinical variables, effectively predicts the risk of developing atrial fibrillation in patients following a cryptogenic stroke or TIA, aiding in the selection of patients for extended rhythm monitoring.
May guide extended monitoring selection after cryptogenic stroke; leaves open prospective validation of clinical impact.
OBJECTIVES: Detection of atrial fibrillation (AF) in post-cryptogenic stroke (CS) or transient ischemic attack (TIA) patients carries important therapeutic implications. METHODS: To risk stratify CS/TIA patients for later development of AF, we conducted a retrospective cohort study using data from 1995 to 2015 in the Stanford Translational Research Integrated Database Environment (STRIDE). RESULTS: Of the 9,589 adult patients (age ≥40 years) with CS/TIA included, 482 (5%) patients developed AF post CS/TIA. Of those patients, 28.4, 26.3, and 45.3% were diagnosed with AF 1-12 months, 1-3 years, and >3 years after the index CS/TIA, respectively. Age (≥75 years), obesity, congestive heart failure, hypertension, coronary artery disease, peripheral vascular disease, and valve disease are significant risk factors, with the following respective odds ratios (95% CI): 1.73 (1.39-2.16), 1.53 (1.05-2.18), 3.34 (2.61-4.28), 2.01 (1.53-2.68), 1.72 (1.35-2.19), 1.37 (1.02-1.84), and 2.05 (1.55-2.69). A risk-scoring system, i.e., the HAVOC score, was constructed using these 7 clinical variables that successfully stratify patients into 3 risk groups, with good model discrimination (area under the curve = 0.77). CONCLUSIONS: Findings from this study support the strategy of looking longer and harder for AF in post-CS/TIA patients. The HAVOC score identifies different levels of AF risk and may be used to select patients for extended rhythm monitoring.
No takes yet. Share an insight, caveat, or question.
Kwong et al. (2017) conducted a cohort in Cryptogenic stroke or transient ischemic attack (n=9,589). HAVOC score was evaluated on Development of atrial fibrillation (AUC 0.77). The HAVOC score, based on 7 clinical variables, successfully stratified patients for atrial fibrillation risk after cryptogenic stroke or TIA with good model discrimination (AUC = 0.77).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: